Rotavirus Vaccine

Cost-Effectiveness of Infant Immunization for Diarrhea Debatable

Published in Vaccine Weekly, May 18th, 1998

A mass vaccination program to curtail rotavirus diarrhea in U.S. children could help avoid more than 34,000 hospitalizations, 95,000 emergency department visits, and be cost-effective when societal and direct medical costs are included.

Costs to society from this disease include travel to seek health care, extra diapers, loss of work time of the caregiver, and lifetime productivity of a dying child.

Roger I. Glass, MD, PhD, from the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia, and colleagues conducted a cost-effectiveness analysis of a national rotavirus immunization program to estimate its economic impact. They presented...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1998-05-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry